| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/B978-0-12-800174-5.00008-9 |
| P698 | PubMed publication ID | 24559919 |
| P50 | author | Andrew Schally | Q141147 |
| Stefan R. Bornstein | Q17126504 | ||
| Barbara Ludwig | Q98957860 | ||
| Norman L Block | Q102145476 | ||
| P2093 | author name string | Stefan Ludwig | |
| Andreas Barthel | |||
| Andreas Reichel | |||
| P2860 | cites work | Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value | Q21092217 |
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| Epidemiologic and economic consequences of the global epidemics of obesity and diabetes | Q22251061 | ||
| RETRACTED: Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets | Q24302717 | ||
| Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation | Q24307581 | ||
| Expression cloning of a human corticotropin-releasing-factor receptor | Q24311371 | ||
| Autologous umbilical cord blood infusion for type 1 diabetes | Q24647362 | ||
| The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes | Q24675521 | ||
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs | Q28115798 | ||
| Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5 | Q28117194 | ||
| Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 | ||
| Changing targets in the treatment of type 2 diabetes | Q28200163 | ||
| Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease | Q28201947 | ||
| Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study | Q28204926 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes | Q28248848 | ||
| Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death | Q40143945 | ||
| Immune intervention at diagnosis--should we treat children to preserve beta-cell function? | Q40161327 | ||
| Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. | Q40239037 | ||
| Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus | Q40581531 | ||
| Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways | Q40813247 | ||
| Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropes | Q40977058 | ||
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | Q28270700 | ||
| Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages | Q28278091 | ||
| Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus | Q28297489 | ||
| CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner | Q28576915 | ||
| Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes | Q28680760 | ||
| Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus | Q28771769 | ||
| Genetic analysis of type 1 diabetes using whole genome approaches | Q28776047 | ||
| Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes | Q29417138 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation | Q29614736 | ||
| Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study | Q29615122 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
| Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis | Q30829257 | ||
| Five-year follow-up after clinical islet transplantation | Q33218078 | ||
| Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial | Q33425402 | ||
| Human adipocytes secrete mineralocorticoid-releasing factors | Q33715978 | ||
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial | Q33999757 | ||
| Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets | Q34004827 | ||
| Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity | Q34110463 | ||
| 11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine | Q34204005 | ||
| Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase | Q34206674 | ||
| Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program | Q34225672 | ||
| Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program | Q34312885 | ||
| Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus | Q34332860 | ||
| Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice | Q34345367 | ||
| A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes | Q34421851 | ||
| Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes | Q34428346 | ||
| Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart | Q34522183 | ||
| Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity | Q34542290 | ||
| Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs | Q34546789 | ||
| Molecular mechanisms of insulin resistance and associated diseases | Q34563946 | ||
| New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies | Q34564255 | ||
| Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study | Q42504591 | ||
| Population impact of strategies for identifying groups at high risk of type 2 diabetes | Q43514642 | ||
| Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up | Q43827414 | ||
| Elevated cortisol levels and increased rates of diabetes and mood symptoms in Soviet Union-born Jewish immigrants to Germany | Q43926892 | ||
| Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes | Q43939892 | ||
| Effects of insulin in relatives of patients with type 1 diabetes mellitus | Q44010590 | ||
| An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes | Q44040130 | ||
| Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. | Q44110772 | ||
| Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women | Q44114894 | ||
| Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice | Q44219623 | ||
| The diabetes risk score: a practical tool to predict type 2 diabetes risk | Q44333486 | ||
| Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid | Q44564028 | ||
| Intranasally administered insulin intended for prevention of type 1 diabetes--a safety study in healthy adults | Q44571008 | ||
| Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone | Q44707250 | ||
| European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes | Q44814113 | ||
| Effect of maternal diet during lactation on development of bovine insulin-binding antibodies in children at risk for allergy | Q44928932 | ||
| Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells | Q44937498 | ||
| Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes | Q45081235 | ||
| Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells | Q45858705 | ||
| Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients | Q45864185 | ||
| Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea | Q46458866 | ||
| Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes | Q46458868 | ||
| Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients | Q46570581 | ||
| Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia | Q46691047 | ||
| Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient | Q46703404 | ||
| New oral antidiabetic agents--clinical perspectives | Q46710458 | ||
| Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea | Q46745719 | ||
| GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis | Q46796844 | ||
| Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark | Q46865193 | ||
| FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression | Q46955933 | ||
| Exposure to environmental factors in drinking water: risk of islet autoimmunity and type 1 diabetes--the BABYDIAB study | Q47685894 | ||
| The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group | Q48033155 | ||
| Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. | Q48041792 | ||
| Is leptin a stress related peptide? | Q48630891 | ||
| Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques | Q50163373 | ||
| Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity | Q51154730 | ||
| Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII). | Q51380418 | ||
| International Diabetes Federation consensus on prevention of type 2 diabetes. | Q51463240 | ||
| Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. | Q51468797 | ||
| Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes. | Q51478119 | ||
| Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. | Q51484798 | ||
| Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. | Q51497444 | ||
| Intracellular cAMP potentiates voltage-dependent activation of L-type Ca2+ channels in rat islet beta-cells. | Q51527031 | ||
| Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. | Q51578750 | ||
| Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nath | Q51918759 | ||
| Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). | Q53235135 | ||
| The defined combination of growth factors controls generation of long-term-replicating islet progenitor-like cells from cultures of adult mouse pancreas. | Q53601223 | ||
| Intensive glycemic control in the ACCORD and ADVANCE trials | Q53654194 | ||
| A missing link in the hygiene hypothesis? | Q53873028 | ||
| Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. | Q55034326 | ||
| Recent enterovirus infection in type 1 diabetes: Evidence with a novel IgM method | Q56774125 | ||
| Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus | Q58201304 | ||
| The European Perspective of Type 2 Diabetes Prevention: Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) Project | Q58417532 | ||
| An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes: Response to Schulze et al | Q58417537 | ||
| Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic -Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling | Q58448979 | ||
| Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells | Q59054474 | ||
| Transdifferentiation of pancreatic ductal cells to endocrine β-cells | Q60192344 | ||
| Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study | Q64378313 | ||
| Receptor-mediated immunomodulation by corticotropin-releasing factor | Q68295560 | ||
| Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen | Q69530151 | ||
| Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease | Q69829052 | ||
| A Polymorphic Locus Near the Human Insulin Gene Is Associated with Insulin-dependent Diabetes Melliitus | Q70314155 | ||
| Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies | Q71150178 | ||
| Identification and characterization of a corticotrophin-releasing hormone receptor in human placenta | Q71795586 | ||
| The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus | Q72340287 | ||
| Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide | Q73167345 | ||
| Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci | Q73403570 | ||
| GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner | Q73842101 | ||
| Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study | Q74607777 | ||
| Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl | Q79306155 | ||
| In utero dietary exposures and risk of islet autoimmunity in children | Q79317253 | ||
| Did the Chernobyl incident cause an increase in Type 1 diabetes mellitus incidence in children and adolescents? | Q79347863 | ||
| Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study | Q79359101 | ||
| Sirolimus improves early microcirculation, but impairs regeneration after pancreatic ischemia-reperfusion injury | Q79570685 | ||
| Clinical translation of "a diabetes outcome progression trial": ADOPT appropriate combination oral therapies in type 2 diabetes | Q80099609 | ||
| Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population | Q80168338 | ||
| Type 1 diabetes: focus on prevention | Q80402893 | ||
| Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells | Q80731025 | ||
| The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes | Q80972975 | ||
| Intrapancreatic adipocyte deposition in a mouse model of the metabolic syndrome | Q81094190 | ||
| A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population | Q81230524 | ||
| [Prevention in occupational health care--a societal challenge] | Q81288952 | ||
| Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope | Q82201101 | ||
| Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. | Q34740438 | ||
| Adaptation to mild, intermittent stress delays development of hyperglycemia in the Zucker diabetic Fatty rat independent of food intake: role of habituation of the hypothalamic-pituitary-adrenal axis | Q34759694 | ||
| In vitro cultivation of human islets from expanded ductal tissue | Q35174217 | ||
| Community-based lifestyle interventions to prevent type 2 diabetes | Q35207016 | ||
| Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus | Q35612872 | ||
| Wnt signaling regulates pancreatic beta cell proliferation | Q35741102 | ||
| Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study | Q35799650 | ||
| Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist | Q35882545 | ||
| Natural history of type 1 diabetes | Q36321536 | ||
| In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 | ||
| The obese patient with diabetes mellitus: from research targets to treatment options | Q36431220 | ||
| Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis | Q36672238 | ||
| Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion | Q36733461 | ||
| Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. | Q36738241 | ||
| Effects of non-steroid immunosuppressive drugs on insulin secretion in transplantation. | Q36742767 | ||
| 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress | Q36833926 | ||
| Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells | Q36842568 | ||
| Stress mechanisms and metabolic complications | Q36853255 | ||
| Newly approved and promising antidiabetic agents | Q36993468 | ||
| The Metabolic Syndrome - a global challenge for prevention | Q36997284 | ||
| The health status of Russian-speaking immigrants in Germany | Q37030731 | ||
| A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus | Q37065857 | ||
| Islet inflammation in type 2 diabetes: from metabolic stress to therapy. | Q37069944 | ||
| Beta cell mass in diabetes: a realistic therapeutic target? | Q37101311 | ||
| Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization | Q37150497 | ||
| Impaired glucose regulation and type 2 diabetes in children and adolescents | Q37190613 | ||
| Pharmacogenetics in diabetes | Q37424309 | ||
| IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus | Q37518209 | ||
| Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets | Q38308587 | ||
| Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture | Q38311023 | ||
| Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly | Q38344746 | ||
| Insulin autoantibodies: their role in the pathogenesis of IDDM. | Q39678759 | ||
| Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway | Q40016200 | ||
| Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis | Q40096446 | ||
| P304 | page(s) | 195-222 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Vitamins and Hormones | Q15753296 |
| P1476 | title | Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus | |
| P478 | volume | 95 |
| Q38735419 | Investigational insulin secretagogues for type 2 diabetes |
| Q40605741 | Islet cell transplantation from Göttingen minipigs to cynomolgus monkeys: analysis of virus safety |
| Q26996481 | The two faces of miR-29 |
| Q41000726 | Xenogeneic cell therapeutics: Treatment of type 1 diabetes using porcine pancreatic islets and islet cells |
Search more.